The Impact of Nonmotor Symptoms on Health-Related Quality of Life in Parkinson’s Disease: A Network Analysis Approach abril 20, 1919abril 20, 2023
Staging Parkinson’s Disease According to the MNCD (Motor/Non-motor/Cognition/Dependency) Classification Correlates with Disease Severity and Quality of Life abril 20, 1919abril 20, 2023
Longitudinal analysis of the Non-Motor Symptoms Scale in Parkinson’s Disease (NMSS): An exploratory network analysis approach. abril 20, 1919abril 20, 2023
Sex Differences in Motor and Non-Motor Symptoms among Spanish Patients with Parkinson’s Disease febrero 15, 1919febrero 15, 2023
Clinical utility of a personalized and long-term monitoring device for Parkinson’s disease in a real clinical practice setting: An expert opinion survey on STAT-ON™ enero 12, 1919enero 12, 2023
Impact of COVID-19 Pandemic on Parkinson´s Disease: A Cross-sectional Survey of 568 Spanish Patients enero 12, 1919enero 12, 2023
Effectiveness of Safinamide over Mood in Parkinson’s Disease Patients: Secondary Analysis of the Open-label Study SAFINONMOTOR enero 12, 1919enero 12, 2023
Pain Improvement in Parkinson´s Disease Treated wirh Safinamide. Results from the SAFINONMOTOR Study enero 12, 1919enero 12, 2023
Safinamide Improves Non-Motor Symptoms Burden in Parkinson’s Disease: An Open-Label Prospective Study enero 12, 1919enero 12, 2023
Safinamide Improves Sleep and Daytime Sleepiness in Parkinson´s Disease. Results from the SAFINONMOTOR Study enero 12, 1919enero 12, 2023
